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Abstract
Background
Rotavirus and HIV infection are major causes of  death among children in sub-Saharan Africa. A previous study reported no association between 
concomitant HIV infection and rotavirus disease severity among hospitalised children in Malawi. This study examined rotavirus antigenaemia and 
broader immune responses among HIV-infected and uninfected children.
Methods
Stored (−80°C), paired sera from acute and convalescent phases of  Malawian children less than 5 years old, hospitalised for acute gastroenteritis 
in the primary study, collected from July 1997 to June 1999, were utilised. Among children older than 15 months, HIV infection was defined as the 
presence of  HIV antibody in the blood, when confirmed by at least 2 established methods. For those younger than 15 months, nested polymerase 
chain reaction (PCR) amplification of  proviral DNA was used for verification. All were followed for up to 4 weeks after hospital discharge. Rotavirus 
antigen levels in sera were measured with Premier™ Rotaclone® rotavirus enzyme immunoassay (EIA) kit. Acute-phase sera were examined for 17 
cytokines, using Luminex fluorescent bead human cytokine immunoassay kit. Rotavirus-specific IgA and neutralising activity were determined by EIA 
and microneutralisation (MN) assay, respectively. Human strains and bovine–human reassortants were propagated in MA104 cells with serum-free 
Iscove’s Modified Dulbecco’s Medium (IMDM). Differences in results, from specimens with and without HIV infection, were analysed for statistical 
significance using the chi-square test.
Results
We detected rotavirus antigen in 30% of  the HIV-infected and 21% HIV-uninfected, in the acute-phase sera. HIV-infected children developed slightly 
prolonged rotavirus antigenaemia compared to HIV-uninfected children.
Conclusions
Rotavirus-specific IgA seroconversion rates and neutralising titres were similar in HIV-infected and HIV-uninfected children, thus, HIV infection had 
no major effect on immune responses to rotavirus infection.
Introduction
Group A rotavirus infection is an important cause of  
paediatric hospitalisation due to severe diarrhoea, and thus 
is a global public health concern. Although rotavirus (RV) 
is ubiquitous and incidence of  rotavirus is similar among 
children in industrial and developing countries, very few 
deaths occur in affluent countries, whereas most rotavirus-
related deaths are in the developing countries of  Asia 
and Africa, with an estimated 243.3 deaths per 100,000 
children under 5 years of  age, annually.1 Similarly, human 
immunodeficiency virus (HIV) infection and acquired 
immune deficiency syndrome (AIDS) remain among the 
most significant public health challenges in these settings, 
with about 3.2 million children under 14 years of  age 
infected with HIV worldwide; approximately 90% of  them 
are in sub-Saharan Africa.2
The high burden of  rotavirus-related diarrhoea occurring 
among children under 5 years old makes vaccination a priority.3 
Two live oral rotavirus vaccines, Rotarix (GlaxoSmithKline, 
human monovalent G1[P8]), and RotaTeq (Merck, 
pentavalent human–bovine reassortant, G1, G2, G3, and 
G4, and P[8]) have been recommended by the World Health 
Organization (WHO) as a part of  the routine programme 
of  childhood immunisation.4 Studies have revealed high 
vaccine efficacy in developed countries, but aberrantly lower 
results in developing countries.5,6 Reasons for lower efficacy 
in low-income countries are not completely understood, 
but suspected factors include maternal antibodies in serum, 
neutralising antibodies in breastmilk, concurrent oral polio 
vaccine administration, malnutrition, strain diversity and co-
infections with other pathogens.7
Rotavirus morbidity and mortality in children could 
potentially be exaggerated by HIV infection, as HIV is 
associated with progressive reduction in CD4 cell count, 
chronic immune activation, and altered levels of  circulating 
cytokines.8 However, studies have shown that children in 
countries of  Asia and sub-Saharan Africa, with high rotavirus 
gastroenteritis-associated fatality rates and with concomitant 
HIV infection, recover from acute rotavirus infections.9,10 
These results paved the way for the WHO recommendation 
that rotavirus vaccines be incorporated into all national 
immunisation programmes.11
Rotavirus infection, previously thought to be localised in the 
epithelial cells of  the lining of  the small intestine, has been 
detected in the blood, body fluids, and tissues, suggesting 
the possibility that rotavirus escapes the intestine into the 
circulatory system.12,13 The primary study examined the effect 
of  concomitant HIV infection on rotavirus gastroenteritis in 
hospitalised Malawian children and found no differences in 
rotavirus severity for those with and without HIV infection. 
Equally, these children recovered from acute rotavirus 
infections.10
In this extended study, we assessed whether rotavirus antigen 
was present in sera, and systematically investigated the possible 
influence of  HIV infection on rotavirus pathogenesis and 
immunity among children in Malawi, by employing a broader 
repertoire of  rotavirus tests for rotavirus antigen, circulating 
cytokines, immunoglobulin A (IgA), and neutralising activity.
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specific IgA and neutralising activity were determined by 
EIA and microneutralisation (MN) assay, respectively.14 
Human strains: Rotarix (G1P[8]), MW333 (G8P[4]) and 
WI61 (G9P[8]); bovine WC3 (G6P[5]); and bovine–human 
reassortants RotaTeq WC3 × WI79-9 (G1P[5]) and WC3 
× W179-4 (G6P[8]) were propagated in MA104 cells with 
serum-free Iscove’s Modified Dulbecco’s Medium (IMDM). 
Differences in results, from specimens with and without 
HIV infection, were analysed for statistical significance using 
the chi-square test.
In the primary study, 6 HIV-positive and 5 HIV-negative 
samples were excluded in the analysis for reasons of  late 
onset of  illness.10 However, we were unable to find original 
records and thus included all samples, with sufficient volume, 
in the present study.
Ethical considerations
The Malawi National Health Sciences Research Committee 
(NHSRC) gave ethical approval and informed consent was 
obtained as documented in the parent study.10 Specimens and 
data were coded with unique identifiers for anonymity, and 
given to the CDC (RD 2010 6007) under a non-disclosure 
agreement which unequivocally prohibits the release of  
personally identifiable information about participants.
Methods
Stored (−80°C), paired sera from acute and convalescent 
phases of  Malawian children under 5 years old, hospitalised 
for acute gastroenteritis in the primary study, collected from 
July 1997 to June 1999, were utilised. Children with and 
without HIV infection were verified. Briefly, among children 
older than 15 months, HIV infection was defined as the 
presence of  HIV antibody in the blood, when confirmed 
by at least 2 established methods. For those younger than 
15 months, nested polymerase chain reaction (PCR) 
amplification of  proviral DNA was used for verification; both 
previously described.10 All were followed for up to 4 weeks 
after hospital discharge. Rotavirus antigen levels in sera were 
measured with Premier™ Rotaclone® Rotavirus enzyme 
immunoassay (EIA) kit (Meridian Diagnostics, Cincinnati, 
OH, USA), according to manufacturer’s instructions. 
Acute-phase sera were examined for 17 cytokines, using 
Luminex fluorescent bead human cytokine immunoassay 
kit (Bio-Plex Pro™ Assays; Bio-Rad Laboratories, Hercules, 
CA, USA), according to manufacturer’s instructions. The 
cytokines examined were IL-1β, IL-2, IL-7, IL-12, IL-
17, IFN-γ, TNF-α, IL-4, IL-5, IL-6, IL-10, IL-13, IL-8, 
G-CSF, GM-CSF, MCP-1(MCAF), and MIP-1β. Rotavirus-
Table 1: Comparison of demographic and rotavirus antigenaemia data by HIV status among children with 
rotavirus diarrhoea in Blantyre, Malawi
Variables
HIV-infected (N = 33) HIV-uninfected (N = 42)
P-value
Frequency (%) Median (Range) Frequency (%) Median (Range)
Age
0-6 months 18 (55%) 4.5 (1-6) 23 (55%) 4.0 (2-6) 0.97
> 6 months 15 (45%) 9.0 (7-17) 19 (45%) 10.0 (7-21) 0.96
Gender
Male 15 (45%) - 23 (55%) - 0.32
Female 18 (55%) - 19 (45%) - 0.33
Rotavirus 
antigenaemia 
Acute phase 10 (30%) 0.10 (0.04-2.11)* 9 (21%) 0.07 (0.04-1.26)* 0.11
Convalescent 
phase 3 (9%) 0.10 (0.04-0.33)* 1 (2%) 0.05 (0.04-0.15)* 0.16
*denotes median (range) of optical density values by Rotaclone EIA test
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Figure 1: Rotavirus-specific IgA titres in acute- and convalescent-phase sera of children, Malawi
Paired sera from (A) total cohort, (B) HIV-infected, and (C) HIV-uninfected were tested for rotavirus IgA as described in the text. Median titre is indicated using 
a black arrow.
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Table 2: Comparison of serology data by HIV status among children with rotavirus diarrhoea in 
Blantyre, Malawi
Variables
HIV-infected HIV-uninfected
P-value
Frequency (%) Median (Range) Frequency (%) Median (Range)
IgA titre N = 33 N = 42
Acute phase 320 (10-5120) 160 (10-5120) 0.48
Convalescent phase 2560 (80-5120) 640 (40-5120) 0.15
Seroconversion* 18 (51%) 21 (50%) 0.24
Microneutralisation titre N = 32 N = 40
Human Rotarix G1P8
Acute phase 80 (1-1280) 80 (1-160) 0.81
Convalescent phase 160 (40-2560) 160 (40-1280) 0.53
Seroconversion* 10 (31%) 10 (25%)
Human MW333 G8P4
Acute phase 20 (1-640) 20 (1-640) 0.61
Convalescent phase 60 (1-2560) 40 (1-2560) 0.79
Seroconversion* 14 (44%) 21 (50%)
Human W161 G9P8
Acute phase 20 (1-10,240) 20 (1-320) 0.81
Convalescent phase 80 (-2560) 160 (1-10,240) 0.91
Seroconversion* 19 (59%) 27 (68%)
Human–bovine 
reassortants
-RotaTeq G1P5
Acute phase 1 (1-40) 1 (1-40) 0.93
Convalescent phase 20 (1-160) 20 (1-320) 0.56
Seroconversion* 6 (19%) 6 (15%)
-RotaTeq G6P8
Acute phase 1 (1-160) 1 (1-40) 0.57
Convalescent phase 1 (1-1280) 1 (1-160) 0.44
Seroconversion* 6 (19%) 3 (8%)
Bovine WC3 G6P5
Acute phase 1 (1-320) 1 (1-40) 0.57
Convalescent phase 1 (1-160) 1 (1-80) 0.60
Seroconversion* 4 (13%) 3 (8%)
*Seroconversion was defined as ≥ fourfold increase in rotavirus-specific IgA and neutralising titres in convalescent-phase sera compared to those in acute-
phase sera
a l  arison of serology d ta by HIV status among children with rotavirus diarrhoea in 
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Results and Discussion
Paired sera, with sufficient volume, were selected from 33 
HIV-positive and 42 HIV-negative children who completed 
the follow-up, displaying comparable demographic variables 
among children with or without HIV infection (Table 1). 
Rotavirus antigen was detected in 19 (25%) of  75 acute-
phase serum samples. This rate was comparable to a report 
in the United States, but was lower than the rates of  43% to 
76% reported in Jamaica, Finland, and Japan.13,15,16
However, in Malawi, rotavirus antigenaemia was slightly 
more prevalent among HIV-infected than the uninfected 
children (30% versus 21%, P = 0.11) in the acute phase and 
similarly, in the convalescent phase (9% and 2%, P = 0.16), 
respectively. Similar reports were observed among HIV-
infected children in Kenya.17 Our detection of  rotavirus 
antigen, in the convalescent phase of  both populations, 3 
to 4 weeks after hospitalisation, is unlike other reports, 
where levels peaked 1 to 3 days after the onset of  acute 
rotavirus gastroenteritis and were undetectable beyond a 
week.15,18 Parallel results were also observed in paired plasma 
specimens from this collection (data not shown), validating 
our results obtained from sera. Our finding of  the prolonged 
rotavirus antigenaemia in HIV-infected children mimics the 
prolonged rotavirus antigen shedding in stool of  children 
from the original study.10
To examine whether HIV infection influenced host immune 
response, we analysed paired sera for rotavirus-specific IgA 
(Table 2). Although median IgA titres were higher in the 
HIV-infected than the HIV-uninfected children, for both the 
acute (320 vs 160) and convalescent (2560 vs 640) phases, 
similar seroconversion rates (51% vs 50%) were observed 
in the 2 populations, respectively. Our seroconversion rates 
were lower than that (76%) in the primary study,10 possibly 
due to sample storage, difference in reagents, assay design, 
and analysis methods.
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HIV-infected patients without AIDS; higher antigenaemia 
was seen in the acute phase of  both immunocompromised 
and non-immunocompromised patients with HIV than in the 
respective convalescent phases. Our results would suggest 
that, overall, HIV-positive children with diarrhoea were more 
likely than their counterparts without HIV infection to have 
rotavirus in their blood.17 Additionally, there was no change 
in the IgA antibody response in the sera of  AIDS patients, 
from the acute to the convalescent phase (geometric mean 
titres [GMT] 453 to 538). In contrast, there was a three-
fold rise in IgA GMT (279 to 845) in HIV-infected patients 
without AIDS, which was similar to a four-fold rise (202 to 
871) in the HIV-uninfected children.
Lastly, we examined a random subset of  acute sera with 
sufficient remaining volume, from 20 HIV-infected and 20 
HIV-uninfected children, for profiles of  17 cytokines (Table 
4). A host typically responds to a viral infection by developing 
innate and adaptive immunity, including production of  
cytokines and antibodies.20 Similarly, rotavirus-activated 
CD8+ cytotoxic T cells have been shown to be involved in 
rotavirus immunity.20 In contrast, HIV infection has been 
associated with progressive reduction in CD4 cell count, 
chronic immune activation, and altered levels of  circulating 
cytokines.8 In this study, we observed little or no cytokine 
differences between the HIV-infected and HIV-uninfected 
children. In addition, we were able to detect levels of  
Table 3: Comparison of rotavirus antigenaemia and IgA titres in children with rotavirus diarrhoea in Blantyre, 
Malawi, according to HIV status and CD4 count
Variables
HIV-infected HIV-uninfected (N = 42)
CD4 count < 500/µL CD4 count ≥ 500/µL CD4 count ≥ 500/µL
Rotavirus antigenaemia N = 4 N = 5 N = 9
Acute phase 2 (50%) 3 (60%) 2 (22%)
Convalescent phase 1 (25%) 1 (20%) 1 (11%)
IgA geometric mean titre N = 4 N = 5 N = 9
Acute phase* 433 (80-2560) 279 (10-2560) 202 (20-2560)
Convalescent phase* 538 (160-2560) 845 (320-2560) 871 (160-2560)
Fold-change from acute to 
convalescent phase 1 3 4
*denotes IgA geometric mean titre (range) in acute- and convalescent-phase sera
Table 4: Profiles of cytokines in sera of children with acute rotavirus diarrhoea in Blantyre, Malawi, by 
HIV status
Cytokines
Paired sera (N = 40) HIV-infected (N = 20) HIV-uninfected (N = 20)
Range Median Range Median Range Median
Pro-inflammatory
IL-1β 2-75 3 2-75 3 0 0
IL-2 1-455 25 1-455 12 1-139 32
IL-7 1-83 1 1-83 2.5 1-21 1
IL-12 1-419 1 1-419 1 1-118 1
IL-17 1-70 1 1-70 1 1-27 2.5
IFN-γ 1-14,112 252 1-14,112 233 1-1820 304.5
TNF-α 1-150 1 1-150 1 1-8 1
Anti-inflammatory
IL-4 1-13 1 1-13 1 1-6 1
IL-5 0-30 1 0-30 1 0-3 1
IL-6 1-673 58.5 1-673 74.5 1-322 56
IL-10 3-415 21.5 5-415 19 3-132 25
IL-13 4-72 5 4-72 5 4-9 5
Chemokines
IL-8 1-477 9 1-388 14 1-477 1.5
G-CSF 1-375 7.5 1-375 17 1-78 1
GM-CSF 1-1667 678 1-1343 576 1-1667 856.5
MCP-1(MCAF) 1-191 74.5 1-191 60 1-140 81
MIP-1β 78-1411 260 78-1411 255.5 167-1397 295.5
Serum cytokines were detected with fluorescently labelled microsphere beads and analysed using standard curves as described in the text. Median 
concentrations (pg/mL) for each cytokine are shown here.
From 1997 to 1999, 
diverse rotavirus strains, 
predominantly G1P[8], 
G8P[6], G3P[8], G8P[4] 
and G4P[8], were present 
in Malawi.19 We therefore, 
analysed 72 paired serum 
samples for neutralising 
activity against 3 human 
(Rotarix G1P[8], MW333 
G8P[4] and WI61 G9P[8]), 
1 bovine (WC3 G6P[5]) and 
2 bovine–human reassortant 
(RotaTeq G1P[5] and 
G6P[8]) rotavirus strains, 
using MN assay (Table 2). 
We found that children 
with natural infection 
developed high titres of  
cross-reactive neutralising 
activity responses against 
homotypic and heterotypic 
human strains. By contrast, 
children developed little or 
no neutralising activity to 
bovine or bovine–human 
reassortant strains. However, 
we observed no significant 
differences in median titres 
of  neutralising activity 
against both human and 
animal strains in the acute and 
convalescent phases between 
the HIV-infected and HIV-
uninfected population. 
To examine if  immune 
status has any effect on 
host response to rotavirus 
infection, we analysed blood 
from HIV-infected children 
who developed AIDS (CD4 
count < 500/µL) compared 
to those who did not develop 
AIDS (CD4 count ≥ 500/
µL), (Table 3). The sample 
size with available CD4 count 
data was small; nonetheless, 
there seemed to be no 
difference in antigenaemia 
between AIDS patients and 
le 3: Comparison of rotavirus antigenaemia and IgA titres in child en with rotavirus diarrhoea
in Blantyre, Malawi, according to HIV status and CD4 count
l  f cytokines in sera of children with acute rotavirus diarrhoea in Blantyre, Malawi, 
by HIV status
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several chemokines and a few pro-inflammatory and anti-
inflammatory cytokines in the early stages of  rotavirus 
diarrhoea. These findings suggest that chemokines may play 
a pivotal role in both inflammatory and immune responses to 
rotavirus infection.9 Accelerant, pro-inflammatory cytokines, 
like IL-1β and TNF-α, which tend to make diseases worse by 
producing fever, inflammation, tissue destruction, shock, and 
even death,21 were detected at low levels in a few subjects of  
this study, corroborating our observations of  overall severe 
disease (severity score ≥ 11) in only 16% of  the study sample 
and high fever (temperature ≥ 39°C) in 19% of  the children. 
On the other hand, as elevated levels of  IL-6 and IFN-γ 
were reported in children with natural rotavirus infection in 
Bangladesh and the United States,22,23  we also detected levels 
of  both pro- and anti-inflammatory cytokines (IL-2, IFN-α, 
IL-6, and IL-10) among Malawian children with rotavirus 
diarrhoea, regardless of  HIV status. In general, similar 
levels of  the 17 cytokines tested were observed in children, 
regardless of  their HIV status, and differences between the 
groups were not significant.
Although the integrity of  our collection of  serum samples, 
from the 1997 to 1999 seasons in Malawi, could have been 
compromised due to collection handling, transportation 
rigors, and long storage time, our findings, in general, were 
similar to those obtained in the primary study, which was 
reported in 2001.10 Our sample size was small, and paired sera 
were not available for all children in the study. In addition, 
because of  the lack of  adequate volumes in these old 
samples, we could not perform all necessary tests, including 
being able to normalise the rotavirus-specific IgA levels.
Our analysis found that children infected with HIV appeared 
to be slightly more likely to develop rotavirus antigenaemia 
and to have longer duration of  antigenaemia than the 
HIV-uninfected children. However, regardless of  HIV 
status, children mounted equivalent cytokine and antibody 
responses to rotavirus infection. Overall, our findings that 
HIV infection had no major effect on rotavirus infection and 
immune response, as determined by rotavirus antigenaemia, 
cytokines, and neutralising antibodies among children in 
Malawi, support the recommendation that children with 
HIV-infection in low-income settings can receive live-
attenuated oral rotavirus vaccine, as part of  the routine 
national immunisation programme, to prevent severe 
dehydrating diarrhoea and deaths.
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